Biotech · Private company
Humanigen, Inc.
Track this companyFree. Adds Humanigen, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- LenzilumabPhase 3 · Coronavirus Disease 2019 (COVID-19) PneumoniaClinicalTrials.gov · fetched Nov 12, 2026
- lenzilumabPhase 1 · Chronic Myelomonocytic Leukemia (CMML)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell LymphomaPHASE1 · TERMINATED · started May 26, 2020ClinicalTrials.gov NCT04314843 · fetched Nov 12, 2026
- Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19PHASE3 · UNKNOWN · started May 5, 2020ClinicalTrials.gov NCT04351152 · fetched Nov 12, 2026
- Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)PHASE1 · COMPLETED · started Jul 1, 2016ClinicalTrials.gov NCT02546284 · fetched Nov 12, 2026